Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KO vs GSK✓SelectedUSD · GSKKO vs GSK performance historyLatest closeAs of-0.71%11/18
Stock and ETF performance explorer

KO vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+104.9%
GSK return
+42.7%
Excess return
+62.3%
Maximum drawdown
-17.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.7%-1.3%+0.6%-0.4%
7D+0.5%-3.1%+3.7%+1.2%
30D+5.0%-0.9%+5.9%+5.1%
3M+11.1%-4.2%+15.3%+12.0%
6M+22.3%-1.6%+23.9%+22.5%
YTD+43.0%+2.6%+40.4%+41.7%
1Y+41.4%+6.2%+35.2%+39.0%
3Y+86.8%+55.0%+31.8%+65.7%
5Y+104.9%+42.8%+62.1%+75.6%
All+104.9%+42.7%+62.3%+75.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling